PlumX Metrics
Embed PlumX Metrics

Testosterone replacement therapy and prostate cancer: A word of caution

Current Sexual Health Reports, ISSN: 1548-3584, Vol: 5, Issue: 1, Page: 31-35
2008
  • 0
    Citations
  • 0
    Usage
  • 43
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Review Description

The number of men for whom testosterone is prescribed is rapidly increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man. Copyright © 2008 by Current Medicine Group LLC.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know